Dry Syrups
| S.N. | GENERIC NAME | COMPOSITION | |
|---|---|---|---|
| 1 | Ceftriaxone Injection I.P. Injection 1 g | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 1 gm. | |
| 2 | Ceftriaxone & Sulbactam for Injection Injection 1.5 g | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 1gm. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 0.5g | |
| 3 | Pantoprazole for Injection Injection 40mg. | Each vial contains: Pantoprazole Sodium (Sterile) Eq. to anhydrous Pantoprazole 40mg | |
| 4 | Ceftriaxone Injection I.P. 250mg | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 250 mg. | |
| 5 | Ceftriaxone Injection I.P. 500mg | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 500 mg | |
| 6 | Piperacillin & Tazobactam for Injection | Each vial contains: Sterile Piperacillin Sodium U.S.P. Eq. to Piperacillin 4gm Sterile Tazobactam Sodium Eq. to Tazobactam 0.5gm | |
| 7 | Cefoperazone & Sulbactam for Injection | Each vial contains: Cefoperazone Sodium(Sterile) I.P. Eq. to anhydrous Cefoperazone 1gm. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 0.5gm | |
| 8 | Ceftazidime & Tazobactam for Injection 1.125 gm | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 1gm Tazobactam Sodium (Sterile) Eq. to Tazobactam 125 mg | |
| 9 | Amoxycillin & Clavulanic Potassium Injection IP 1.2 g | Each vial contains: Amoxycillin Sodium(Sterile) I.P. Eq. to anhydrous Amoxycillin 1000 mg Clavulanate Potassium(Sterile) I.P. Eq. to Clavulanic Acid 200 mg | |
| 10 | Cefoperazone & Sulbactam for 1gm. | Each vial contains: Cefoperazone Sodium(Sterile) I.P. Eq. to anhydrous Cefoperazone 0.5gm. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 0.5gm | |
| 11 | Diclofenac Sodium Injection 1ml | Each ml. contains: Diclofenac Sodium I.P. 75mg Benzyl Alcohol I.P 4%v/v (As Preservative) Water for Injection I.P. q.s. | |
| 12 | Methylcobalamin + Vitamin B6 + Niacinamide Injection 2 ml | Each 2ml contains: Methylcobalamin 1000 mcg Pyridoxine HCl IP 100 mg Niacinamide IP 100 mg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 13 | Methylcobalamin + Vitamin B6 + Niacinamide Injection 2 ml | Each 2ml contains: Methylcobalamin JP 1500 mcg Pyridoxine HCl IP 100 mg Niacinamide IP 100 mg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 14 | Nandrolone Decanoate Inj .I P 50 mg | Each ml contains: Nandrolone Decanoate IP 50 mg Benzyl Alcohol IP 2 % v/v (as preservative) Ethyl oleate IP qs | |
| 15 | Ondansetron Injection I.P. 2ml | Each ml. contains: Ondansetron HCl I.P. Eq. to Ondansetron 2mg Water for inj. I.P. q.s. | |
| 16 | Nandrolone Decanoate Inj .I P 25 mg | Each ml contains: Nandrolone Decanoate IP 25 mg Benzyl Alcohol IP 2 % v/v (as preservative) Ethyl oleate IP qs | |
| 17 | Methylcobalamin + Vitamin B6 + Niacinamide Injection 2 ml | Each 2 ml contains: Methylcobalamin JP 2500 mcg Pyridoxine HCl IP 100 mg Niacinamide IP 100 mg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 18 | Tramadol Injection. 2ml | Each ml. contains: Tramadol HCl I.P. 50 mg Water for inj. I.P. q.s. | |
| 19 | Amikacin Sulphate Injection . I.P. 2ml 500mg. | Each 2ml. contains: Amikacin Sulphate I.P. Eq. to Amikacin base 500mg Methylparaben I.P. 0.18%w/v (As preservative) Propylparaben I.P. 0.02%w/v (As preservative) Water For Injection I.P. q.s. | |
| 20 | Amikacin Sulphate Injection . I.P. 2ml 250mg. | Each 2ml. contains: Amikacin Sulphate I.P. Eq. to Amikacin base 250mg Methylparaben I.P. 0.18%w/v (As preservative) Propylparaben I.P. 0.02%w/v (As preservative) Water For Injection I.P. q.s. | |
| 21 | Carboxymethylcellulose Sodium Eye Drop IP | Composition: Sodium Carboxymethylcellulose IP 0.5 % w/v Stabilized Oxychloro Complex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 22 | Carboxymethylcellulose Sodium Eye Drop IP | Composition: Sodium Carboxymethylcellulose IP 1 % w/v Stabilized Oxychloro Complex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 23 | Moxifloxacin & Flurbiprofen Eye Drop | Composition: Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Flurbiprofen Sodium 0.03% w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 24 | Moxifloxacin &Tobramycin Eye Drop | Composition: Tobramycin sulphate USP eq.to tobramycin 0.3 % w/v Moxifloxacin hydrochloride IP Eq to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.02% v/v (as preservative) Sterile Aqueous vehicle qs | |
| 25 | Moxifloxacin Eye Drop IP | Composition: Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 26 | Flurbiprofen & HPMC Eye Drops | Composition: Flurbiprofen Sodium IP 0.03% w/v Hydroxypropylmethylcellulose IP 0.25 % w/v Sterile Aqueous vehicle qs | |
| 27 | Naphazoline HCl Eye Drop | Composition: Naphazoline HCl IP 0.05% w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 28 | Nepafenac Ophthalmic Suspension | Composition: Nepafenac 0.1 w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 29 | Polyethylene Glycol 400 & Propylene Glycol Eye Drops | Composition: Polyethylene Glycol 400 NF 0.4 % w/v Propylene Glycol IP 0.3% w/v Sterile Aqueous Vehicle qs | |
| 30 | Paradichlorobenzene , Chlorbutol , Turpentine oil & Benzocaine Ear Drops | Composition: Paradichlorobenzene 2%w/v Chlorbutol IP 5 %w/v Turpentine oil BP 15 % w/v Benzocaine IP 2.7 % w/v Oily Excipients qs | |
| 31 | Ofloxacin | Clotrimazole & Lignocaine Ear DropsComposition: Ofloxacin IP 0.3%w/v Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Non aqueous base qs | |
| 32 | Ofloxacin , Beclomethasone Dipropionate ,Clotrimazole & Lignocaine Ear Drops | Composition: Ofloxacin IP 0.3w/v Beclomethasone Dipropionate IP 0.25 %w/v Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Non aqueous base qs | |
| 33 | Clotrimazole & Lignocaine Ear Drops | Composition: Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Non aqueous base qs | |
| 34 | Xylometazoline Nasal Drop IP | Composition: Xylometazoline Hydrochloride IP 0.1%W/V Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 35 | Xylometazoline Nasal Drop IP | Composition: Xylometazoline Hydrochloride IP 0.05%W/V Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 36 | Normal Saline Nasal Drops | Composition: Sodium Chloride IP 0.65w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Purified water IP qs | |
| 37 | Chloramphenicol , Beclomethasone Dipropionate , Clotrimazole & Lignocaine Ear Drops | Each ml. contains: Chloramphenicol IP 5%w/v Beclomethasone Dipropionate IP 0.025 %w/v Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Non aqueous base qs | |
| 38 | Sodium bicarbonate, Phenol & Glycerin ear drops | Each ml contains: Sodium bicarbonate IP 34 mg Phenol IP 0.0034ml Glycerin IP .34ml Water for Injection IP qs | |
| 39 | Ketorolac Tromethamine Ophthalmic Solution | Composition: Ketorolac Tromethamine IP 0.5 % w/v Benzalkonium chloride Solution IP 0.02 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 40 | Ceftriaxone Injection I.P. 4 g For veterinary use only | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 4gm | |
| 41 | Meloxicam & Paracetamol Injection 30/9/08 FOR VET USE | Each ml contains: Meloxicam IP 5 mg Paracetamol IP 150 mg Benzyl Alcohol IP 2 %v/v (as preservative) Water For Injection IP qs | |
| 42 | Amoxycillin & Cloxacillin for Injection 4 g FOR VET USE | Each vial contains: Amoxycillin Sodium(Sterile) I.P. Eq. to anhydrous Amoxycillin 2 gm. Cloxacillin Sodium(Sterile) I.P.. Eq. to anhydrous Cloxacillin 2 gm | |
| 43 | Methylcobalamin Injection | Each 2ml contains: Methylcobalamin 1500 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 44 | Iron Sucrose Injection USP | Each ml contains Ferric Hydroxide in complex With sucrose equivalent to Elemental Iron 20 mg Water for Injection qs | |
| 45 | Ceftriaxone & Tazobactam for Injection 281.25 mg | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 250 mg Tazobactam Sodium(Sterile) Eq. to anhydrous Tazobactam 31.25 mg | |
| 46 | Ofloxacin ophthalmic Solution IP | Composition: Ofloxacin IP 0.3w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Aqueous vehicle qs | |
| 47 | Methylcobalamin Injection | Each 1ml contains: Methylcobalamin JP 1500 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 48 | Methylcobalamin Injection | Each 2ml contains: Methylcobalamin JP 1500 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 49 | Methylcobalamin Injection | Each 1ml contains : Methylcobalamin JP 2500 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 50 | Artesunate for Injection 60 mg. | Each vial contains: Artesuante (Sterile) I.P. Eq. to anhydrous Artesuante 60 mg | |
| 51 | Pantoprazole for Injection 40mg. | Each vial contains: Pantoprazole Sodium (Sterile) Eq. to anhydrous Pantoprazole 40mg | |
| 52 | Ketorolac Tromethamine Injection | Composition: Ketorolac Tromethamine IP 30mg Water for Injection IP qs | |
| 53 | Ceftazidime for Injection I.P 1 g | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 1 g. ( Sterile blend of Ceftazidime Pentahydarate IP Sodium Cabonate IP) | |
| 54 | Amikacin Sulphate Injection . I.P. 2ml 100mg. | Each 2ml. contains: Amikacin Sulphate I.P. Eq. to Amikacin base 100mg Methylparaben I.P. 0.18%w/v (As preservative) Propylparaben I.P. 0.02%w/v (As preservative) Water For Injection I.P. q.s. | |
| 55 | Methylcobalamin Injection | Each 2ml contains : Methylcobalamin JP 2500 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 56 | Olopatadine Ophthalmic Solution USP | Composition: Olopatadine hydrochloride USP Eq. to Olopatadine 0.1 w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 57 | Meropenem Injection I.P. 1 g | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 1 g. (a sterile mixture of meropenem & sodium carbonate) | |
| 58 | Arteether Injection . 2ml | Each 2ml. contains: Alpha Beta Arteether IP 150 mg Ethyl oleate IP qs | |
| 59 | Piracetam Injection 15ml | Each ml. contains: Piracetam IP 200 mg Water for Injection IP qs | |
| 60 | Ceftriaxone & Sulbactam for Injection | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 250 mg. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 125 mg | |
| 61 | Moxifloxacin & Prednisolone Acetate Eye Drop | Composition: Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Prednisolone Acetate USP 1% w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 62 | Meropenem Injection I.P. 500mg | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 500mg. (a sterile mixture of meropenem & sodium carbonate) | |
| 63 | Ceftazidime Injection I.P. 125 mg | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 125 mg. ( Sterile blend of Ceftazidime Pentahydarate IP & Sodium Carbonate IP) | |
| 64 | Piroxicam & Paracetamol Injection FOR VET USE | Each ml contains: Piroxicam IP 20 mg Paracetamol IP 150 mg Benzyl Alcohol IP 2% v/v (as preservative) Water For Injection IP qs | |
| 65 | Moxifloxacin &Tobramycin Eye Drop | Composition: Tobramycin sulphate USP eq.to tobramycin 0.3 % w/v Moxifloxacin hydrochloride IP Eq to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.02% v/v (as preservative) Sterile Aqueous vehicle qs | |
| 66 | Moxifloxacin & Dexamethasone Eye Drop | Composition: Dexamethasone Sodium Phosphate I.P 0.1 % w/v Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.02v/v (as preservative) Sterile Aqueous base qs | |
| 67 | Tramadol Injection . 2ml | Each ml. contains: Tramadol HCl I.P. 50 mg Water for inj. I.P. q.s. | |
| 68 | Meropenem & Sulbactam Injection 1.5 g | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 1 g. (a sterile mixture of meropenem & sodium carbonate IP) Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 0.5gm | |
| 69 | Tobramycin & Fluoromethalone Eye Drop | Composition: Tobramycin sulphate USP eq.to tobramycin 0.3 % w/v Fluoromethalone USP 0.1 w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 70 | Flurbiprofen Eye Drops IP 14/11/2009 | Composition: Flurbiprofen Sodium IP 0.03% w/v Sterile Aqueous vehicle qs | |
| 72 | L-Ornithine L-Aspartate Injection | Each 10ml contains: L-Ornithine L-Aspartate 5gm Water For Injection IP qs | |
| 73 | Moxifloxacin & Loteprednol Etabonate Eye Drop | Composition: Loteprednol Etabonate 0.5 % w/v Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 74 | Olopatadine Ophthalmic Solution USP | Composition: Olopatadine hydrochloride USP Eq. to Olopatadine 0.2 w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 75 | Piroxicam Injection 2 ml | Each ml contains: Piroxicam IP 20 mg Benzyl Alcohol IP 2% v/v (as preservative) Water For Injection IP qs | |
| 76 | Piperacillin & Tazobactam for Injection 1.125 g | Each vial contains: Sterile Piperacillin Sodium USP. Eq. to Piperacillin 1000mg Sterile Tazobactam Sodium Eq. to Tazobactam 125mg | |
| 77 | Piperacillin & Tazobactam for Injection 2.25 | Each vial contains: Sterile Piperacillin Sodium USP. Eq. to Piperacillin 2000mg Sterile Tazobactam Sodium Eq. to Tazobactam 250mg | |
| 78 | Levetiracetam Injection 5 ml | Each ml contains: Levetiracetam 100 mg Water for Injection IP qs | |
| 79 | Triamcinolone Acetonide Injection . I.P. 1ml 40 mg | Each ml. contains: Triamcinolone Acetonide I.P. 40 mg Benzyl Alcohol I.P. 1.5 % v/v (As preservative) Water For Injection I.P. q.s. | |
| 80 | Methylcobalamin Injection | Each ml contains: Methylcobalamin 500 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 81 | Timolol Maleate Eye Drop IP | Composition: Timolol Maleate IP Eo. to Timolol 0.5 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 82 | Drotaverine Injection . 2ml | Each ml. contains: Drotaverine HCl I.P. 20 mg Water for inj. I.P. q.s. | |
| 83 | Hypermellose Ophthalmic Solutions usp | Composition: Hydroxypropylmethylcellulos IP 0.3 % w/v Sterile Aqueous Vehicle qs | |
| 84 | Ceftazidime & Tazobactam for Injection | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 125 mg. Tazobactam Sodium (Sterile) Eq. to Tazobactam 15.625 mg | |
| 85 | Itraconazole eye drops | Composition: Itraconazole BP 1%W/V Sterile Aqueous vehicle qs | |
| 86 | Piroxicam, Pitofenone HCl & Fenpiverinium Bromide Injection | Each ml contains: Piroxicam IP 10 mg Pitofenone Hydrochloride 2 mg Fenpiverinium Bromide 0.02 mg Benzyl Alcohol IP 2% v/v (as preservative) Water For Injection IP qs | |
| 87 | Carboxymethylcellulose Sodium &Acetyl Carmosine Eye Drops | Composition: Sodium Carboxymethylcellulose IP 0.5 % w/v N-Acetyl L-Carmosine 1.0 % w/v Boric Acid IP 0.1 % w/v Glycerine IP 0.5 % w/v Stabilized Oxychlorocomplex 0.0075 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 88 | Analgin & diphenhydramine inj. For veterinary use only | Each ml contains: Analgin IP 375 mg Diphenhydramine Hcl IP 20mg Benzyl Alcohol IP 2 % v/v (as preservative) Water for inj IP qs | |
| 89 | Cyclopentolate hydrochloride Eye Drop | Composition: Cyclopentolate hydrochloride USP 1 % w/v Benzalkonium chloride Solution IP 0.02v/v (as preservative) Sterile Aqueous base qs | |
| 90 | DIFLUPREDNATE OPTHALMIC EMULSION 0.05% | Composition: Difluprednate 0.05 w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 91 | Sodium acid phosphate & Methylcobalamine injection | Each ml contains: Sodium acid phosphate IP 400 mg Methylcobalamine 100 mcg Water For Injection IP qs | |
| 92 | OLAPATADINE | CPM & HPMC EYE DROP Composition: Olapatadine Hydrochloride USP Eq. to Olapatadine 0.1 %w/v Chlorpheniramine Maleate IP 0.01 % w/v Hydroxypropylmehtylcellulose IP 0.25 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 93 | Sodium acid phosphate injection | Each ml contains: Sodium acid phosphate IP 40.3%w/v Eq. to elemental phosphate 80mg Methyl Paraben I.P. 0.18%w/v Propyl Paraben I.P. 0.02%w/v (both preservative) Water For Injection I.P. q.s. | |
| 94 | FLOROMETHOLONE + Tobramycin Eye Drops | Composition: Fluoromethalone IP 0.1 w/v Tobramycin Sulphate USP Eq to Tobramycin 0.3 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 95 | Potassium Iodide,Calcium Chloride & Sodium Chloride Eye Drop | Composition: Potassium Iodide IP 3.3 % w/v Sodium Chloride IP 0.83 w/v Calcium Chloride(ANHYDROUS) IP 1.325 % w/v Phenylmercuric Nitrate 0.001%w/v (as preservative) Sterile Aqueous vehicle qs | |
| 96 | Moxifloxacin,Tobramycin & HPMC Eye Drop | Composition: Tobramycin sulphate USP eq.to tobramycin 0.3 % w/v Moxifloxacin hydrochloride IP Eq to Moxifloxacin 0.5 % w/v Hydroxypropylmethylcellulos IP 0.25 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 97 | Tropicamide and Phenylepherine Eye Drops | Composition: Tropicamide IP 0.8% w/v Phenylepherine Hydrochloride IP 5 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 98 | Potassium Iodide,Calcium Chloride & Sodium Chloride Eye Drop | Composition: Potassium Iodide IP 3.3 % w/v Calcium Chloride IP 1 % w/v Sodium Chloride IP 0.83%w/v Benzalkonium chloride Solution IP 0.02% w/v (as preservative) Sterile Aqueous vehicle qs | |
| 99 | Gentamicin, Beclomethasone Dipropionate, Clotrimazole & Lignocaine HCl ear drops | Composition: Gentamicin Sulphate I.P. Eq. to Gentamicin 0.3%w/v Beclomethasone Dipropionate IP 0.025 %w/v Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) oily base qs | |
| 100 | Meloxicam Injection FOR VET USE | Each ml contains: Meloxicam IP 20 mg Benzyl Alcohol IP 2 %v/v (as preservative) Water For Injection IP qs | |
| 101 | Meropenem Injection I.P. 250mg | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 250mg. (a sterile mixture of meropenem & sodium carbonate) | |
| 102 | Triamcinolone Acetonide Injection . I.P. 1ml 10 mg | Each ml. contains: Triamcinolone Acetonide I.P. 10 mg Benzyl Alcohol I.P. 1.5 % v/v (As preservative) Water For Injection I.P. q.s. | |
| 103 | Nimesulide & Paracetamol Injection FOR VET USE | Each ml contains: Nimesulide BP 100 mg Paracetamol IP 150 mg Benzyl Alcohol IP 2 %v/v Water For Injection IP qs | |
| 104 | Nimesulide Injection FOR VET USE | Each ml contains: Nimesulide BP 100 mg Benzyl Alcohol IP 2 %v/v Water For Injection IP qs | |
| 105 | Olopatadine,Fluoromethalone & HPMC Eye Drop | Composition: Fluoromethalone USP 0.1 %w/v Olopatadine hydrochloride USP Eq. to Olopatadine 0.1% w/v HPMC IP 0.25% w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Aqueous vehicle qs | |
| 106 | Naphazoline,Camphor,Menthol, Chlorpheniramine Maleate Eye Drop | Composition: Naphazoline HCl IP 0.056 % w/v Chlorpheniramine Maleate IP 0.01 %w/v Boric Acid IP 1.25 % w/v Camphor IP 0.01 % w/v Menthol IP 0.005 %w/v Sodium Carboxymethylcellulose IP 0.5 % w/v Stabilized Oxychlorocomplex 0.0075 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 107 | Citicoline Injection I.P. | Each ml. contains: Citicoline Sodium I.P Eq to Citicoline 250 mg Water for Injection I.P. q.s. | |
| 108 | Naphazoline HCl,CPM & HPMC Eye Drop | Composition: Naphazoline HCl IP 0.056% w/v Chlorpheniramine Maleate IP 0.01 %w/v HPMC IP 0.25 % w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 109 | Methylcobalamin + Folic Acid + Niacinamide Injection | Each ml contains: Methylcobalamin JP 2500 mcg Folic Acid IP 0.7 mg Niacinamide IP 12 mg Benzyl Alcohol IP 2 % v/v Water for Injection IP qs | |
| 110 | Moxifloxacin & Ketorolac Eye Drop | Composition: Ketorolac Tromethamine IP 0.5 % w/v Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.0075 w/v Sterile Aqueous vehicle qs | |
| 111 | Naphazoline, Boric Acid , Chlorpheniramine Maleate, Sodium chloride Eye Drop | Composition: Naphazoline HCl IP 0.056 % w/v Boric Acid IP 1.25 % w/v Chlorpheniramine Maleate IP 0.01 %w/v Sodium chloride IP 0.05%w/v Carboxymethylcellulose sodium IP 0.5%w/v Sterile Aqueous vehicle qs | |
| 112 | Tranexamic Acid Injection IP. | Each ml. contains: Tranexamic Acid I.P. 100 mg Water for inj. I.P. q.s. | |
| 113 | Tobramycin SulphateInjectionUSP Injection 2ml 80mg. | Each 2ml. contains: Tobramycin Sulphate USP Eq. to Tobramycin 80mg Water For Injection I.P. q.s. | |
| 114 | Cefepime & Tazobactam for Injection 1.125 g | Each vial contains: Cefepime Hydrochloride (Sterile) I.P. Eq. to anhydrous Cefepime (sterile mixture of Cefepime & L-Arginine ) 1 g. Tazobactam Sodium(Sterile) Eq. to anhydrous Tazobactam 0.125 g | |
| 115 | Ofloxacin & Dexamethasone Phosphate Eye Drop | Composition: Dexamethasone Sodium Phosphate IP Eq to Dexamethasone Phosphate 0.1 %w/v Ofloxacin IP 0.3 % w/v Benzalkonium chloride Solution IP 0.02 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 116 | Hydrocortisone Sodium Succinate Injection IP 100 mg | Each vial contains: Hydrocortisone Sodium Succinate I.P. Eq. to anhydrous Hydrocortisone 100 mg. | |
| 117 | Ceftazidime Injection I.P. 250 mg | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 250 mg. ( Sterile blend of Ceftazidime Pentahydarate IP & Sodium Carbonate IP) | |
| 118 | Ceftazidime & Tazobactam for Injection 281.25 mg | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 250 mg. ( Sterile blend of Ceftazidime Pentahydarate IP Sodium Cabonate IP) Tazobactam Sodium (Sterile) Eq. to anhydrous Tazobactam 31.25 mg | |
| 119 | Ceftriaxone & Tazobactam for Injection 1.125 g. | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 1 g. Tazobactam Sodium(Sterile) Eq. to anhydrous Tazobactam 0.125 g | |
| 120 | Meropenem Injection I.P. 125 mg | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 125 mg (a sterile mixture of meropenem & sodium carbonate) | |
| 121 | Ceftriaxone & Sulbactam for Injection 750mg | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 500 mg. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 250 mg | |
| 122 | Naphazoline,Camphor,Menthol, Chlorpheniramine Maleate Eye Drop | Composition: Naphazoline HCl IP 0.056 % w/v Chlorpheniramine Maleate IP 0.01 %w/v Boric Acid IP 1.25 % w/v Camphor IP 0.01 % w/v Menthol IP 0.005 %w/v Sodium Carboxymethylcellulose IP 0.5 % w/v Stabilized Oxychlorocomplex 0.0075 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 123 | Moxifloxacin & Ketorolac Eye Drop | Composition: Ketorolac Tromethamine IP 0.4 % w/v Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Benzalkonium chloride Solution IP 0.0075 w/v Sterile Aqueous vehicle qs | |
| 124 | Carboxymethylcellulose Sodium & Glycerin Eye Drops | Composition: Sodium Carboxymethylcellulose IP 0.5 % w/v Glycerin IP 1 % w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 125 | Piracetam Injection 60ml | Each ml. contains: Piracetam IP 200 mg Water for Injection IP qs | |
| 126 | Naphazoline HCl,CPM & HPMC Eye Drop | Composition: Naphazoline HCl IP 0.1% w/v Chlorpheniramine Maleate IP 0.01 %w/v HPMC IP 0.25 % w/v Boric Acid IP 1.25%w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 127 | Carboxymethylcellulose Sodium & Glycerin Eye Drops | Composition: Sodium Carboxymethylcellulose IP 0.5 % w/v Glycerin IP 0.5 % w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 128 | MethylprednisoloneAcetate Injection IP 2ml | Each ml. contains: Methylprednisolone Acetate I.P. 40mg (Micronised) Benzyl Alcohol I.P 2%v/v (As Preservative) Water for Injection I.P. q.s. | |
| 129 | Naphazoline, Chlorpheniramine Maleate, Boric Acid, Sodium Chloride ophthalmic Solution | Composition: Naphazoline HCl IP 0.056 % w/v Boric Acid IP 1.25 % w/v Sodium Chloride IP 0.05%w/v Zinc sulphate IP 0.12%w/v Chlorpheniramine Maleate IP 0.01 %w/v Hydroxypropylmethylcellulose IP 0.25 % w/v Stabilized Oxychlorocomplex 0.0075 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 130 | Ofloxacin , Beclomethasone Dipropionate ,Clotrimazole & Lignocaine Ear Drops | Composition: Ofloxacin IP 0.3w/v Beclomethasone Dipropionate IP 0.025 %w/v Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Non aqueous base qs | |
| 131 | Artesunate for Injection 120 mg. | Each vial contains: Artesuante (Sterile) I.P. Eq. to anhydrous Artesuante 120 mg | |
| 132 | Olopatadine & Ketorolac Tromethamine Ophthalmic Solution | Composition: Olopatadine hydrochloride USP Eq. to Olopatadine 0.1 w/v Ketorolac Tromethamine IP 0.4 % w/v Benzalkonium chloride Solution IP 0.01 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 133 | Naphazoline HCl , Methyl cellulose,Chlorpheniramine Maleate & Zinc sulphate ophthalmic solution | Composition: Naphazoline HCl USP 0.1 % w/v Methyl cellulose IP 0.2%w/v Chlorpheniramine Maleate IP 0.01 %w/v Zinc sulphate IP 0.012%w/v Benzalkonium chloride Solution IP 0.02 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 134 | Ampicillin & Sulbactam for Injection 3 g | Each vial contains: Ampicillin Sodium(Sterile) I.P. Eq. to anhydrous Ampicillin 2gm. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 1g | |
| 135 | Meropenem & Tazobactam Injection 1.125 g | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 1 g. (a sterile mixture of meropenem & sodium carbonate IP) Tazobactam Sodium (Sterile) Eq. to Tazobactam 125 mg | |
| 136 | Cefoperazone & Tazobactam for Injection 1.125 g | Each vial contains: Cefoperazone Sodium(Sterile) I.P. Eq. to anhydrous Cefoperazone 1gm. Tazobactam Sodium (Sterile) Eq. to Tazobactam 125 mg | |
| 137 | Moxifloxacin & Difluprednate Ophthalmic Emulsion 5 ml | Composition: Moxifloxacin hydrochloride IP Eq to Moxifloxacin 0.5 % w/v Difluprednate 0.05% w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 138 | D-Panthenol & Sodium Hyaluronate eye drop | Composition: D-Panthenol IP 5% w/v Sodium Hyaluronate BP 0.1%w/v Stabilized Oxychloro Complex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 139 | Sodium hyaluronate eye drop | Composition: Sodium hyaluronate BP 0.1% w/v Stabilized Oxychloro Complex 0.005 w/v (as preservative) Aqueous buffered vehicle q.s | |
| 140 | Mefenamic Acid & Paracetamol Injection For veterinary use only | Each ml contains: Mefenamic Acid IP 50mg Paracetamol IP 150mg Benzyl Alcohol IP 2 % v/v (as preservative) Water For Injection IP qs | |
| 141 | Tobramycin Ophthalmic Solution USP | Composition: Tobramycin sulphate USP eq.to tobramycin 0.3 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 142 | Ofloxacin & Dexamethasone Sodium Phosphate Eye Drop | Composition: Dexamethasone Sodium Phosphate 0.1 %w/v Ofloxacin IP 0.3 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 143 | OLAPATADINE | CPM & HPMC EYE DROP Composition: Olapatadine Hydrochloride USP Eq. to Olapatadine 0.1 %w/v Chlorpheniramine Maleate IP 0.01 % w/v Hydroxypropylmehtylcellulose IP 0.25 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 144 | Carboxymethylcellulose Sodium & Glycerin Eye Drops | Composition: Sodium Carboxymethylcellulose IP 0.5 % w/v Glycerin IP 1 % w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 145 | Carboxymethylcellulose Sodium & Glycerin Eye Drops | Composition: Sodium Carboxymethylcellulose IP 1 % w/v Glycerin IP 0.5 % w/v Stabilized Oxychlorocomplex 0.005 w/v (as preservative) Sterile Aqueous vehicle qs | |
| 146 | Olopatadine & Ketorolac Eye Drop | Composition: Ketorolac Tromethamine IP 0.4 % w/v Olopatadine hydrochloride USP Eq. to Olopatadine 0.1 w/v Hydroxypropylmehtylcellulose IP 0.25 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 147 | Fluconazole Eye Drop | Composition: Fluconazole 0.3 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 148 | Fluorometholone & Polyvinyl Alcohol Opthalmic Suspension | Composition: Fluoromethalone USP 0.1 w/v Polyvinyl Alcohol IP 1.4 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 149 | Methylcobalamin Injection | Each ml contains: Methylcobalamin 1000 mcg Benzyl Alcohol IP 2 % v/v (as preservative) Water for Injection IP qs | |
| 150 | Nandrolone Phenyl propionate Injection .I P 50mg | Each ml contains: Nandrolone Phenyl propionate IP 50 mg Benzyl Alcohol IP 2 % v/v (as preservative) Ethyl oleate IP qs | |
| 151 | Nandrolone Phenyl propionate Injection .I P 25mg | Each ml contains: Nandrolone Phenyl propionate IP 25 mg Benzyl Alcohol IP 2 % v/v (as preservative) Ethyl oleate IP qs | |
| 152 | Ondansetron Injection I.P. | Each ml. contains: Ondansetron HCl I.P. Eq. to Ondansetron 2mg Water for inj. I.P. q.s. | |
| 153 | Acetylcysteine Injection BP | Each ml contains: Acetylcysteine BP 200 mg Water for Injection IP qs | |
| 154 | Cefoperazone & Sulbactam for Injection 2 gm | Each vial contains: Cefoperazone Sodium(Sterile) I.P. Eq. to anhydrous Cefoperazone 1gm. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 1gm | |
| 155 | Ceftriaxone & Tazobactam for Injection | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 125mg Tazobactam Sodium(Sterile) Eq. to anhydrous Tazobactam 15.625mg | |
| 156 | Hydrocortisone Sodium Succinate Injection IP 200 mg | Each vial contains: Hydrocortisone Sodium Succinate I.P. Eq. to anhydrous Hydrocortisone 200 mg. | |
| 157 | Cefuroxime Injection I.P. | Each vial contains: Cefuroxime Sodium(Sterile) I.P. Eq. to anhydrous Cefuroxime 1.5 gm. | |
| 158 | Cefuroxime Injection I.P. 750mg | Each vial contains: Cefuroxime Sodium(Sterile) I.P. Eq. to anhydrous Cefuroxime 750mg. | |
| 159 | Cefuroxime Injection I.P. 375mg | Each vial contains: Cefuroxime Sodium(Sterile) I.P. Eq. to anhydrous Cefuroxime 375mg. | |
| 160 | Ceftriaxone & Sulbactam for Injection 3 g | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 2gm. Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 1g | |
| 161 | Loteprednol Etabonate Eye Drop | Composition: Loteprednol Etabonate 0.2 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 162 | Ceftriaxone Injection I.P. Injection 2 g | Each vial contains: Ceftriaxone Sodium(Sterile) I.P. Eq. to anhydrous Ceftriaxone 2 gm. | |
| 163 | Ivermectin Injection For veterinary use only | Each ml contains: Ivermectin IP 10 mg Benzyl Alcohol IP 2% v/v Propylene Glycol IP qs | |
| 164 | OLOPATADINE OPHTHALMIC SOLUTION USP | Composition: Olopatadine hydrochloride USP Eq. to Olopatadine 0.1 w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 165 | Meropenem & Sulbactam Injection 750mg | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 500mg (a sterile mixture of meropenem & sodium carbonate IP) Sulbactam Sodium(Sterile) Eq. to anhydrous Sulbactam 250mg | |
| 166 | Ceftriaxone Injection USP 1 g FOR EXPORT ONLY | Each vial contains: Ceftriaxone Sodium(Sterile) USP Eq. to anhydrous Ceftriaxone 1 gm. | |
| 167 | Glutathione for Injection 600mg | Each vial contains: Glutathione 600mg | |
| 168 | Bromfenac ophthalmic solution 0.09% | Composition: Bromfenac 0.09 %w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 169 | Ivermectin Injection For veterinary use only | Each ml contains: Ivermectin IP 10 mg Benzyl Alcohol IP 3% v/v Propylene Glycol IP qs | |
| 170 | Ceftazidime Injection I.P. 500 mg | Each vial contains: Ceftazidime(Sterile) I.P. Eq. to anhydrous Ceftazidime 500 mg. ( Sterile blend of Ceftazidime Pentahydarate IP & Sodium Carbonate IP) | |
| 171 | Ketorolac Tromethamine & Dexamethasone Sodium Phosphate Eye Drop | Composition: Ketorolac Tromethamine IP 0.5 % w/v Dexamethasone Sodium Phosphate IP 0.1 %w/v Benzalkonium chloride Solution IP 0.02 %v/v (as preservative) Sterile Aqueous vehicle qs | |
| 172 | Triamcinolone Acetonide Injection . I.P. 1ml 40 mg | Each ml. contains: Triamcinolone Acetonide I.P. 40 mg Preservative free Water For Injection I.P. q.s. | |
| 173 | Fluorometholone Opthalmic Suspension USP | Composition: Fluoromethalone USP 0.1% w/v Benzalkonium chloride solution IP 0.02%v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 174 | Natamycin Ophthalmic Suspension USP | Composition: Natamycin USP 5.0% w/v Benzalkonium chloride solution IP 0.02%v/v (as preservative) Sterile Aqueous Vehicle qs | |
| 175 | Cefpirome & Sulbactam for Injection Injection 1.5 g | Each vial contains: Cefpirome Suplhate(Sterile) Eq. to anhydrous Cefpirome 1000mg Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 500mg | |
| 176 | Meropenem & Sulbactam Injection 2 g | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 1 g. (a sterile mixture of meropenem & sodium carbonate IP) Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 1gm | |
| 177 | Neomycin Sulphate , Beclomethasone Dipropionate ,Clotrimazole & Lignocaine Ear Drops | Composition: Neomycin Sulphate IP 0.5w/v Beclomethasone Dipropionate IP 0.25 %w/v Clotrimazole IP 1 % w/v Lignocaine HCl IP 2 % w/v Benzalkonium chloride solution IP 0.02v/v (as preservative) Glycerrin IP & Propylene Glycol IP base qs | |
| 178 | Ceftriaxone for Injection USP 1 g FOR EXPORT ONLY | Each vial contains: Ceftriaxone Sodium(Sterile) USP Eq. to anhydrous Ceftriaxone 1gm With WFI | |
| 179 | Ceftriaxone for Injection USP 500mg FOR EXPORT ONLY | Each vial contains: Ceftriaxone Sodium(Sterile) USP Eq. to anhydrous Ceftriaxone 500mg. With WFI | |
| 180 | Ceftriaxone for Injection USP 250mg FOR EXPORT ONLY | Each vial contains: Ceftriaxone Sodium(Sterile) USP Eq. to anhydrous Ceftriaxone 250mg With WFI | |
| 181 | Moxifloxacin Eye Drop IP | Composition: Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Sterile Aqueous vehicle qs | |
| 182 | Azithromycin eye drops | Composition: Azithromycin (As Dihydrate) I.P. Eq. to Azithromycin anhydrous 1%w/v Benzalkonium chloride solution IP 0.02%v/v (as preservative) Sterile Aqueous vehicle qs | |
| 183 | Hypromellose Ophthalmic Solutions USP 0.3% | Composition: Hydroxypropylmethylcellulos IP 0.3 % w/v Stabilized Oxychloro Complex 0.005 w/v (as preservative) Sterile Aqueous Vehicle qs | |
| 184 | Moxifloxacin, Loteprednol Etabonate & Tobramycin Eye Drop | Composition: Loteprednol Etabonate 0.5 % w/v Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Tobramycin sulphate USP eq.to tobramycin 0.3 % w/v Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 185 | Moxifloxacin, Loteprednol Etabonate & Polymyxin B Sulphate Eye Drop | Composition: Loteprednol Etabonate 0.5 % w/v Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 0.5 % w/v Polymyxin B Sulphate 5000IU Benzalkonium chloride Solution IP 0.02 v/v (as preservative) Sterile Aqueous vehicle qs | |
| 186 | Nepafenac Ophthalmic Suspension | Composition: Nepafenac 0.1 w/v Stabilized Oxychloro Complex 0.01 w/v (as preservative) Sterile Aqueous Vehicle qs | |
| 187 | Meropenem & Sulbactam Injection 2 g | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 1 g. (a sterile mixture of meropenem & sodium carbonate IP) Sulbactam Sodium(Sterile) U.S.P. Eq. to anhydrous Sulbactam 1gm | |
| 188 | Meropenem & Tazobactam Injection 1.250 g | Each vial contains: Meropenem (Sterile) I.P. Eq. to anhydrous Meropenem 1 g. (a sterile mixture of meropenem & sodium carbonate IP) Tazobactam Sodium (Sterile) Eq. to Tazobactam 250 mg | |